期刊文献+

肿瘤抑素抗血管活性相关肽对宫颈癌Hela细胞生长和转移抑制作用的实验研究 被引量:1

Inhibition of growth and metastasis of human cervical carcinoma cell implanted in nude mice by recombinant anti-angiogenic peptides of tumstatin
原文传递
导出
摘要 目的研究改造后的血管生成抑制相关肽(21肽)抗血管生成活性及对人宫颈癌Hela细胞皮下移植裸鼠模型的抑制作用,探讨其抑瘤作用机制。方法2005年8月至2006年2月哈尔滨医科大学第一临床医学院进行Hela细胞株皮下接种裸鼠造模,21肽治疗3周后,处死动物剥离肿瘤,称重并计算抑瘤率。免疫组化方法检测21肽对肿瘤组织的微血管密度(MVD)、增殖细胞核抗原(PCNA)和血管内皮生长因子(VEGF)的影响。结果21肽组平均抑瘤率可达51.89%,肿瘤组织微血管密度明显降低,与对照组比较差异有统计学意义(P<0.05);21肽组肿瘤组织的PCNA、VEGF呈低表达,与对照组比较差异有统计学意义(P<0.05)。结论21肽具有显著的抗血管生成活性,可明显地抑制裸鼠宫颈癌细胞的生长,其抑制宫颈癌的作用机制可能与其降低新生血管形成和调解血管生成相关因子的表达有关。 Objective To study the biological activity of recombinant anti-angiogenic peptides of tumstatin (21 Peptides) and its inhibitory action on the growth and metastasis of human cervical carcinoma cell (Hela) implanted in nude mice, and to investigate into the mechanism of its inhibitory action. Methods The human cervical carcinoma cell line Hela was implanted subcutaneously in nude mice. The 21 peptides were administered for twenty-one days. Then mice were killed, tumors were weighed and the restrained percentage of tumor were calculated. In addition, the microvessel density (MVD) ,the positive rate of vascular endothelial growth factor (VEGF) and the proliferating cell nuclear antigen (PCNA) index were detected by immunohistochemical methods. Results In 21 peptides group, the restrained percentage of tumor was 51.89%. The MVD, expression of the PCNA index and the positive rate of VEGF in 21 peptides group all descended ( all P 〈 0. 05 ). Conclusion The above data indicate that the 21 peptides can significantly restrain the development of mice cervical cancer. The mechanism may be relevant to its effects of antiangiogensis and decreasing proliferation.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2007年第6期427-429,共3页 Chinese Journal of Practical Gynecology and Obstetrics
基金 国家自然科学基金(30472035)
关键词 宫颈癌 肿瘤抑素 21肽 肿瘤细胞增殖核抗原 血管内皮细胞生长因子 微血管密度 Cervical cancer Tumstatin 21 Peptides Proliferating cell nuclear antigen Vascular endothelial growth factor Microvessel density
  • 相关文献

参考文献12

  • 1Holash J,Wiegand SJ,Yancopolos GD.New model of tumor angiogenesis:dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF[J].Oncogene,1999,18(5):356-362.
  • 2Maeshima Y,Yerramalla UL,Dhanabal M,et al.Extracellular matrix-derived peptide binds to alpha(v)beta(3)integrin and inhibits angiogenesis[J].J Biol Chem,2001,276(34):31959-31968.
  • 3付雪,王淑静,林雪松,刘兴汉.肿瘤抑素抗血管活性相关肽的表达及活性研究[J].医学分子生物学杂志,2005,2(3):157-161. 被引量:8
  • 4王洛伟,金冠球,王喜安,沈宾鸿,卞俊,肖正达,徐根兴.血管内皮抑素基因制剂对肝癌的实验研究[J].中华消化杂志,2001,21(6):335-338. 被引量:8
  • 5Kitadai Y,Haruma K,Tokutomi T,et al.Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas[J].Clin Cancer Res,1998,4:2195-2200.
  • 6Folkman J,D'Amore PA.Blood vessel formation:what is its molecular basis?[J].Cell,1996,87:1153-1155.
  • 7Burrows FJ,Watanabe Y,Thorpe PE,et al.A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors[J].Cancer Res,1992,52:5954-5962.
  • 8Nelson NJ.Inhibitors of angiogenesis enter phase Ⅲ testing[J].J Natl Cancer Inst,1998,90:960-963.
  • 9Hamano Y.Physiological levels of tumstatin,a fragment of collagen Ⅳ alpha 3 chain,are generated by MMP-9 proteolysis and suppress angiogenesis via alpha Ⅴ beta 3 integrin[J].Cancer Cell,2003,3(6):p589-601.
  • 10Maeshima Y,Lively JC.Tumstatin,an endothelial cell specific inhihitor of protein synthesis[J].Science,2002,295(2):p140-143.

二级参考文献30

  • 1余琼,周凌云,刘兴汉,徐建永,王淑静,周宏博,林雪松.重组人成骨生长肽治疗去卵巢大鼠骨质疏松的实验观察[J].中国地方病学杂志,2004,23(4):318-320. 被引量:3
  • 2余琼,周凌云,林雪松,徐建永,王淑静,刘兴汉.重组人成骨生长肽的表达、纯化和活性的研究[J].中国生物化学与分子生物学报,2004,20(4):467-472. 被引量:14
  • 3Lund E L,Acta Neurol Scand,1998年,97卷,52页
  • 4O'Reilly M S,Cell,1997年,88卷,277页
  • 5徐根兴,发明专利公告,1998,14 ,45, CN1177005
  • 6SambrookJ RussellDW 黄培堂 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.32-50.
  • 7Holash J, Wiegand SJ, Yancopolos GD.New model of tu-mor angiogenesis:dynamic balance between vesses regrewssion and growth mediates by angiopoietins and VEGF.Oncogene,1999,18(5):356-62.
  • 8Bergers G, Benjamin LE.Tumorigensis and the angiogenic switch.Nat Rev Cancer, 2003,3(6):401-10.
  • 9Maeshima Y, Yerramalla UL, Dhanabal M, et al.Extrace-llular matrix derived peptide binds to αVβ3 integrin and inhibits angiogenesis.J Biol Chem,2001,276(34):31 959-68.
  • 10Maeshima Y, Colorado PC, Kalluri R.Two RGD-independent αVβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.J Biol Chem, 2000, 275(31):23 745-50.

共引文献26

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部